TRIM3 and neoplasm: Significantly, we detected genomic dosage alterations of TRIM3 in two glioma cases with LOH at 11p15.5, indicating homozygous deletions of TRIM3. Our LOH and Q-PCR data therefore suggest that TRIM3 may act as a tumor suppressor in the human brain.